Quick Answer
SPRUCE BIOSCIENCES, INC. reported R&D Expense of $19.52 million for fiscal year 2025.
SPRUCE BIOSCIENCES, INC. R&D Expense — Annual History
| Fiscal Year | R&D Expense | YoY Change |
|---|---|---|
| 2025 | $19.52M | -57.9% |
| 2024 | $46.42M | -6.1% |
| 2023 | $49.43M | +40.4% |
| 2022 | $35.20M | +14.7% |
| 2021 | $30.70M | +28.7% |
| 2020 | $23.85M | +120.5% |
| 2019 | $10.82M | — |
Quarterly R&D Expense
| Quarter Ending | R&D Expense | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $5.01M | -23.5% | +1265.3% |
| June 30, 2025 | -$430.0K | -105.3% | -104.0% |
| March 31, 2025 | $10.84M | +5.0% | +65.3% |
| September 30, 2024 | $6.55M | -51.4% | -19.0% |
| June 30, 2024 | $8.09M | -38.4% | -21.6% |
| March 31, 2024 | $10.32M | -11.9% | -23.5% |
| September 30, 2023 | $13.49M | +53.5% | +2.8% |
| June 30, 2023 | $13.13M | +44.9% | +12.1% |
- SPRUCE BIOSCIENCES, INC. showed a decrease of -57.9% in R&D Expense compared to the prior fiscal year.
- Over the 2019–2025 period, SPRUCE BIOSCIENCES, INC.’s r&d expense has grown by 80.5% (from $10.82 million to $19.52 million).
- The most recent figure is from SPRUCE BIOSCIENCES, INC.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 9, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: